Co-evolution in HIV enzymes

BIOINFORMATICS 2010 - Proceedings of the 1st International Conference on Bioinformatics

Volumn , Issue , 2010, Pages 39-47

  Boba, P ^a   Weil, P ^a   Hoffgaard, F ^a   Hamacher, K ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Co evolution; Data mining; HIV; Human immunodeficiency virus; Machine learning; Mutual information; Sequence analysis

Indexed keywords

CO-EVOLUTION; HIV; HUMAN IMMUNODEFICIENCY VIRUS; MACHINE-LEARNING; MUTUAL INFORMATIONS; SEQUENCE ANALYSIS;

AMINO ACIDS; BIOINFORMATICS; BIOLOGY; CATALYSTS; DATA MINING; ENZYMES; LEARNING SYSTEMS; ORGANIC ACIDS; VIRUSES;

DISEASES;

EID: 77952957266     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (29)

1. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local alignment search tool. J Mol Biol, (3):403-410.
2. Boba, P. and Hamacher, K. (2009). http://bioserver.bio.tu-darmstadt.de/ HIV.
3. Chen, L. and Lee, C. (2006). Distinguishing HIV-1 drug resistance, accessory, and viral fitness mutations using conditional selection pressure analysis of treated versus untreated patient samples. Biology Direct, 1(1): 14.
4. Chen, L., Perlina, A., and Lee, C. J. (2004). Positive Selection Detection in 40, 000 Human Immunodeficiency Virus (HIV) Type 1 Sequences Automatically Identifies Drug Resistance and Positive Fitness Mutations in HIV Protease and Reverse Transcriptase. J. Virol., 78(7):3722-3732.
5. Finn, R. D., Tate, J., Mistry, J., Coggill, P. C., Sammut, S. J., Hotz, H.-R., Ceric, G., Forslund, K., Eddy, S. R., Sonnhammer, E. L. L., and Bateman, A. (2008). The Pfam protein families database. Nucl. Acids Res., 36:D281-D288.
6. Gloor, G., Martin, L., Wahl, L., and Dunn, S. (2005). Mutual information in protein multiple sequence alignments reveals two classes of coevolving positions. Biochemistry, 44(19):7156-7165.
7. Hamacher, K. (2007). Information theoretical measures to analyze trajectories in rational molecular design. J. Comp. Chem., 28(16):2576-2580.
8. Hamacher, K. (2008). Relating sequence evolution of HIV 1 -protease to its underlying molecular mechanics. Gene, 422:30-36.
9. Hamacher, K. and McCammon, J. A. (2006). Computing the amino acid specificity of fluctuations in biomolecular systems. J. Chem. Theory Comput., 2(3):873-878.
10. Higgins, D. G. and Sharp, R M. (1988). Clustal: a package for performing multiple sequence alignment on a microcomputer. Gene, 73(1):237-244.
11. Humphrey, W., Dalke, A., and Schulten, K. (1996). VMD - Visual Molecular Dynamics. Journal of Molecular Graphics, 14:33-38.
12. Lund, O., Nielsen, M., Lundegaard, C., and Brunak, C. K. S. (2005). Immunological Bioinformatics. MIT Press, Cambridge.
13. Pan, C., Kim, J., Chen, L., Wang, Q., and Lee, C. (2007). The hiv positive selection mutation database. Nuc. Acids Res., 35:D371-D375(1).
14. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J., and Ho, D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science, 271:1582-1586.
15. Perryman, A. L., Lin, J.-H., and McCammon, J. A. (2006). Restrained molecular dynamics simulations of hiv-1 protease: The first step in validating a new target for drug design. Biopolymers, 82(3):272-284.
16. Prajapati, D. G., Ramajayam, R., Yadav, M. R., and Girid-har, R. (2009). The search for potent, small molecule nnrtis: A review. Bioorganic & Medicinal Chemistry, 17(16):5744-5762.
17. Reiling, K., Endres, N., Dauber, D., Craik, C., and Stroud, R. (2002). Anisotropic dynamics of the JE-2147-HIV protease complex: Drug resistance and thermodynamic binding mode examined in a 1.09 a structure. Biochemistry, 41:4582.
18. Richman, D., Maigolis, D., Delaney, M., Greene, W. C., Hazuda, D., and Pomerantz, R. J. (2009). The challenge of finding a cure for HIV infection. Science, 323:1304-1307.
19. Rong, L., Gilchrist, M. A., Feng, Z., and Perelson, A. S. (2007). Modeling within-host HIV-1 dynamics and the evolution of drug resistance: Trade-offs between viral enzyme function and drug susceptibility. J. Theo. Biol., 247:804-818.
20. Sarafianos, S. G., Das, K., Hughes, S. H., and Arnold, E. (2004). Taking aim at a moving target: designing drugs to inhibit drug-resistant hiv-1 reverse transcriptases. Current Opinion in Structural Biology, 14(6):716-30.
21. Schreck, T., Bremm, S., Held, S., and Hamacher, K. (2009). to be published.
22. Shannon, C. E. (1951). Prediction and entropy of printed english. The Bell System Technical Journal, 30:50-64.
23. Stone, J. (1998). An Efficient Library for Parallel Ray Tracing and Animation. Master's thesis, Computer Science Department, University of Missouri-Rolla.
24. Thompson, J., Higgins, D., and Gibson, T. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22:4673-4680.
25. Trylska, J., Tozzini, V., Chang, C., and McCammon, J. A. (2007). HIV-1 protease substrate binding and product release pathways explored with coarse-grained molecular dynamics. Biophys. J., 92:4179-4187.
26. Tsygankov, A. Y. (2009). Current developments in anti-HIV/AIDS gene therapy. Curr Opin Investig Drugs, 10(2): 137-149.
27. W.H. Press et al (1995). Numerical Recipies in C. Cambridge University Press, Cambridge.
28. Wlodawer, A. and Erickson, J. (1993). Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem., 62(1):543-585.
29. Yoshimura, K., Kato, R., Yusa, K., Kavlick, M. F., Maroun, V. and Nguyen, A., Mimoto, T., Ueno, T., Shintani, M., Falloon, J., Masur, H., Hayashi, H., Erickson, J., and Mitsuya, H. (1999). JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc. Natl. Acad. Sci., 96:8675-8680.